著者
Hideaki ABE Manabu NATSUMEDA Yu KANEMARU Jun WATANABE Yoshihiro TSUKAMOTO Masayasu OKADA Junichi YOSHIMURA Makoto OISHI Yukihiko FUJII
出版者
The Japan Neurosurgical Society
雑誌
Neurologia medico-chirurgica (ISSN:04708105)
巻号頁・発行日
vol.58, no.7, pp.290-295, 2018 (Released:2018-07-15)
参考文献数
49
被引用文献数
8 26

Histone H3 mutations are frequently found in diffuse midline gliomas (DMGs), which include diffuse intrinsic pontine gliomas and thalamic gliomas. These tumors have dismal prognoses. Recent evidence suggests that one reason for the poor prognoses is that O6-methylguanine-DNA methyltransferase (MGMT) promoter frequently lacks methylation in DMGs. This review compares the epigenetic changes brought about by histone mutations to those by isocitrate dehydrogenase-mutant gliomas, which frequently have methylated MGMT promoters and are known to be sensitive to temozolomide.

言及状況

外部データベース (DOI)

Twitter (2 users, 2 posts, 1 favorites)

In Diffuse Midline Gliomas - Histone H3 mutation, diffuse DNA are hypomethylated , thus MGMT promoter is unmethylated, it renders DMGs resistant https://t.co/GcnVOqgSGF
IDH変異型のグリオーマやDiffuse Midline Gliomaにおける MGMTの発現及び治療抵抗性についてのレビュー ・IDH変異ではDNAが広範にメチル化される→MGMTプロモーターもメチル化→MGMT発現せず、テモゾロミド奏功 ・DMGではDNAメチル化がされない→テモゾロミド効果薄い https://t.co/Cy3Puhvbyk

収集済み URL リスト